In a world first, scientists grow new ears for children with microtia
In a landmark study for the tissue engineering community, scientists have successfully grown and reconstructed new ears for children born with a birth defect.
Scientists in China have successfully grown and reconstructed new ears for five children born with microtia, a condition that affects the function and appearance of the ear. The recent study marks a new milestone in the field of tissue engineering.
A paper published in the journal EBioMedicine outlines how the team performed the procedure.
The researchers used cartilage cells collected from patients’ affected ears to grow new cartilage in vitro. They 3D-printed mirrored copies of each patient’s healthy ear to use as scaffolding into which the new cartilage could grow, ensuring that the new ears would be the right shape for each individual. Finally, the scientists attached and reconstructed the new ears onto the patients.
“We were able to successfully design, fabricate, and regenerate patient-specific external ears,” wrote the researchers.
Reconstructing the ears of microtia patients has been a goal of the tissue engineering community for decades. The condition affects as many as 17.4 out every 10,000 children in some countries, in degrees ranging from a slightly smaller ear (on one side or both) to a completely missing ear, a condition known as anotia. It cripples hearing ability; one doctor wrote that hearing with microtia is similar to placing a finger in your ear, and can also damage self-confidence.
The study signals new hope for children afflicted with microtia, but the procedure may prove difficult to implement on a large scale.
Lawrence Bonassar, a biomedical engineering professor at Cornell University who wasn’t involved in the study, told CNN:
“The method for making these constructs is quite complicated, involving three distinct biomaterials that are combined into a scaffold, seeded with cells, then cultured for three months before implantation to ensure proper cell distribution throughout the construct.”
Scaling up the procedure for thousands of microtia patients would be a difficult task, he said.
“Secondly, the materials that are used for these scaffolds remain in the body for a long time: up to four years... Such implants would likely need to be monitored for four or five years before the ultimate fate of these materials in the body is known.”
Still, the results of the recent study are positive.
“Tissue engineered auricle is a promising alternative to current ear reconstructive options, but its clinical translation is yet to be accomplished,” the researchers wrote. “In the current study, cartilage frameworks with patient-specific ear shapes and proper mechanical strength were successfully engineered in vitro. Using these engineered ear frameworks, we performed external ear reconstruction on 5 patients and achieved satisfactory therapeutic outcome as revealed during 2.5 years' follow-up so far.”